Second primary malignant neoplasm in patient with ovarian cancer – case report

Increase in the occurrence of multiple primary malignant tumours is associated with significant extention of survival rate among patients treated for malignant neoplasm. Treatment of multiple primary malignant tumours demands precise clinical evaluation, imaging, laboratory diagnostics and histopathological evaluation of the lesion. In the presented case immunohistochemical staining of lymphatic metastasis from nasopharyngeal carcinoma was mimicking distant metastasis from poorly differentiated ovarian cancer. It impeded histopathological diagnosis and required additional imaging enriched by PET-CT, which allowed the visualization of the second tumor.

Download Full-text

Pedunculated Sub-Serous Leiomyosarcoma Mimicking Ovarian Cancer: Case Report and Review of Literature

Gynecology & Obstetrics ◽

10.4172/2161-0932.1000157 ◽

2013 ◽

Vol 03 (03) ◽

Author(s):

Takuhei Yokoyama

Keyword(s):

Ovarian Cancer ◽

Case Report ◽

Cancer Case ◽

Review Of Literature ◽

Ovarian Cancer Case

Download Full-text

A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study

Molecular & Cellular Proteomics ◽

10.1074/mcp.ra119.001531 ◽

2019 ◽

Vol 18 (11) ◽

pp. 2191-2206 ◽

Cited By ~ 2

Author(s):

Róisín O'Flaherty ◽

Mohankumar Muniyappa ◽

Ian Walsh ◽

Henning Stöckmann ◽

Mark Hilliard ◽

...

Keyword(s):

Ovarian Cancer ◽

Acute Phase ◽

Acute Phase Proteins ◽

Cancer Case ◽

Serum Antibodies ◽

Ovarian Cancer Case

Download Full-text

Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer

Case Reports in Oncological Medicine ◽

10.1155/2014/940591 ◽

2014 ◽

Vol 2014 ◽

pp. 1-5 ◽

Cited By ~ 3

Author(s):

K. N Srinivasan ◽

Amit Rauthan ◽

R. Gopal

Keyword(s):

Ovarian Cancer ◽

Cancer Case ◽

First Line Therapy ◽

Ovarian Cancer Case ◽

First Case ◽

Long Term Follow Up ◽

Third Line ◽

Line Chemotherapy

Background. Ovarian cancer is the ninth most common cancer among women and causes more deaths than any other type of female reproductive cancer. Albumin-bound paclitaxel is known to increase intratumoral concentration of the paclitaxel by a receptor-mediated transport process across the endothelial cell wall, thereby breaching the blood/tumor interface. We present below three cases in which nab-paclitaxel based chemotherapy has been used in different settings for patients with ovarian cancer.Case Presentation. In the first case nab-paclitaxel was used along with carboplatin in adjuvant setting, in the second case, nab-paclitaxel was used along with carboplatin and bevacizumab as second line chemotherapy in a relapsed ovarian cancer case, and the third case delineates the use of nab-paclitaxel along with cisplatin as third line chemotherapy.Conclusion. In all the three scenarios, patients tolerated the chemotherapy well, as well as responding well to nab-paclitaxel based chemotherapy. The patients are currently on long-term follow-up and have been having an uneventful postchemotherapy.

Download Full-text

Intestinal lymphangitis carcinomatosa related to ovarian cancer: Case report and review of the literature

Gynecologic Oncology Reports ◽

10.1016/j.gore.2020.100606 ◽

2020 ◽

Vol 33 ◽

pp. 100606

Author(s):

Ricardo Pedrini Cruz ◽

Gustavo Peretti Rodini ◽

Margarete Duarte da Rosa ◽

Vinicius Duarte Cabral ◽

Eduardo Cambruzzi ◽

...

Keyword(s):

Ovarian Cancer ◽

Case Report ◽

Cancer Case ◽

Review Of The Literature ◽

Ovarian Cancer Case ◽

Lymphangitis Carcinomatosa

Download Full-text

European American Stratification in Ovarian Cancer Case Control Data: The Utility of Genome-Wide Data for Inferring Ancestry

PLoS ONE ◽

10.1371/journal.pone.0035235 ◽

2012 ◽

Vol 7 (5) ◽

pp. e35235 ◽

Cited By ~ 2

Author(s):

Paola Raska ◽

Edwin Iversen ◽

Ann Chen ◽

Zhihua Chen ◽

Brooke L. Fridley ◽

...

Keyword(s):

Ovarian Cancer ◽

Case Control ◽

Cancer Case ◽

European American ◽

Control Data ◽

Ovarian Cancer Case ◽

Genome Wide ◽

Genome Wide Data

Download Full-text

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

BioMed Research International ◽

10.1155/2015/183523 ◽

2015 ◽

Vol 2015 ◽

pp. 1-8 ◽

Cited By ~ 9

Author(s):

Michele L. Santangelo ◽

Carmen Criscitiello ◽

Andrea Renda ◽

Stefano Federico ◽

Giuseppe Curigliano ◽

...

Keyword(s):

Second Primary ◽

Second Primary Malignancy ◽

Primary Malignancy ◽

Predisposing Factor ◽

Multiple Cancers ◽

Multiple Primary Malignancies ◽

Multiple Primary ◽

Second Tumor ◽

Tumor Types

Immunodeficiency is associated with higher cancer incidence. However, it is unknown whether there is a link between immunodeficiency and development of multiple primary malignancies. In the present study we analyse this link focusing on kidney-transplanted patients, as they are at higher risk of developing cancer due to the chronic assumption of immunosuppressants. We followed up 1200 patients who underwent kidney transplantation between 1980 and 2012. A total of 77/1200 kidney-transplanted patients developed cancer and 24 of them developed multiple cancers. Most multiple cancers were synchronous with a nonsignificant association between cancer and rejection episodes. In the general cancer population, one-ninth of patients are at higher risk of developing a second tumor over a lifetime; hence it would be reasonable to conclude that, from a merely theoretical and statistical viewpoint, long-term transplanted patients potentially have a higher risk of developing MPMs. However, data did not confirm this assumption, probably because these patients die before a second primary malignancy appears. Despite many observations on the increased incidence of different tumor types in immunodeficient patients and despite immunosuppression certainly being a predisposing factor for the multicancer syndrome, data so far are not robust enough to justify a correlation between immunodeficiency and multiple primary malignancies in transplanted patients.

Download Full-text

A successful ovarian cancer case

International Journal of Cancer Research & Therapy ◽

10.33140/ijcrt.06.02.02 ◽

2021 ◽

Vol 6 (2) ◽

Keyword(s):

Ovarian Cancer ◽

Electrical Properties ◽

Cancer Diagnostics ◽

Cancer Case ◽

Ovarian Cancer Case

A lady discovered she had ovarian cancer in 2016 and was treated by CellSonic. The tumour remained big and had to be surgically removed after the cancer was stopped. Since then, cancer diagnostics have progressed and the electrical properties can now be easily detected allowing CellSonic to advance from stopping cancer in a patient to stopping cancer in a population. The patient is well and has approved this article.

Download Full-text